ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2026年第一次临时股东会的通知 | 2026-02-27 | Chinese | |
| 睿智医药2025年限制性股票激励计划（草案修订稿）摘要 | 2026-02-27 | Chinese | |
| 北京市竞天公诚律师事务所上海分所关于睿智医药科技股份有限公司2025年限制性股票激励计划调整事项之法律意见书 | 2026-02-27 | Chinese | |
| 睿智医药2025年限制性股票激励计划实施考核管理办法（修订稿） | 2026-02-27 | Chinese | |
| 董事、高级管理人员薪酬管理制度 | 2026-02-27 | Chinese | |
| 睿智医药2025年限制性股票激励计划（草案修订稿） | 2026-02-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 36046783 | 关于召开2026年第一次临时股东会的通知 | 2026-02-27 | Chinese | ||
| 36046782 | 睿智医药2025年限制性股票激励计划（草案修订稿）摘要 | 2026-02-27 | Chinese | ||
| 36046774 | 北京市竞天公诚律师事务所上海分所关于睿智医药科技股份有限公司2025年限制性股票激励计划调整事项之法律意见书 | 2026-02-27 | Chinese | ||
| 36046773 | 睿智医药2025年限制性股票激励计划实施考核管理办法（修订稿） | 2026-02-27 | Chinese | ||
| 36046772 | 董事、高级管理人员薪酬管理制度 | 2026-02-27 | Chinese | ||
| 36046771 | 睿智医药2025年限制性股票激励计划（草案修订稿） | 2026-02-27 | Chinese | ||
| 36046766 | 简式权益变动报告书（梁玉凤） | 2026-02-09 | Chinese | ||
| 36046757 | 关于持股5%以上股东减持至5%以下暨权益变动的提示性公告 | 2026-02-09 | Chinese | ||
| 36046746 | 简式权益变动报告书（于显文） | 2026-02-09 | Chinese | ||
| 36046743 | 2025年度业绩预告 | 2026-01-30 | Chinese | ||
| 36046735 | 关于担保进展的公告 | 2026-01-22 | Chinese | ||
| 36046723 | 关于持股5%以上股东减持股份的预披露公告 | 2026-01-15 | Chinese | ||
|
2025
3 filings
| |||||
| 36046718 | 关于关联方对全资子公司增资进展暨完成工商登记的公告 | 2025-12-22 | Chinese | ||
| 36046704 | 关于担保进展的公告 | 2025-12-19 | Chinese | ||
| 36046694 | 关于高级管理人员辞职的公告 | 2025-12-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bonus BioGroup Ltd.
A clinical-stage biotech firm developing cell therapy and t…
|
BONS | IL | Professional, scientific and te… |
|
BPH GLOBAL LTD
Biotech firm focused on plant-based health products and fun…
|
BP8 | AU | Professional, scientific and te… |
|
BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical,…
|
BNN | DE | Professional, scientific and te… |
|
BriaCell Therapeutics Corp.
Clinical-stage immuno-oncology company developing cellular …
|
BCTX | CA | Professional, scientific and te… |
|
Bright Minds Biosciences Inc.
Developing innovative serotonin-based drugs for neurologica…
|
DRUG | CA | Professional, scientific and te… |
|
BRIM Biotechnology, Inc.
Develops therapies for ophthalmology and degenerative disea…
|
6885 | TW | Professional, scientific and te… |
|
BSF ENTERPRISE PLC
Develops cell-based solutions for cultivated meat, leather,…
|
BSFA | GB | Professional, scientific and te… |
|
BullFrog AI Holdings, Inc.
A technology company applying AI and machine learning to dr…
|
BFRG | US | Professional, scientific and te… |
|
Burning Rock Biotech Ltd
A global diagnostics company specializing in precision onco…
|
BNR | US | Professional, scientific and te… |
|
Cabaletta Bio, Inc.
Develops engineered T cell therapies for B cell-mediated au…
|
CABA | US | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.